The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti–melanoma differentiation–associated gene 5 antibody
Abstract
Objective: To investigate the clinical features of dermatomyositis (DM) and clinically amyopathic DM (CADM) patients with the presence of anti–melanoma differentiation–associated gene 5 (anti–MDA‐5) antibodies. Methods: We screened the serum anti–MDA‐5 antibody levels of 140 patients with various connective tissue diseases (CTDs), including 32 with DM and 32 with CADM, or idiopathic pulmonary fibrosis (IPF). The clinical courses of DM/CADM patients with a positive expression of anti–MDA‐5 antibodies were delineated. Results: Anti–MDA‐5 antibodies were detected at a significantly higher frequency in CADM patients than in DM patients (12 of 32 versus 3 of 32; P = 0.016), but were not detected in patients with other CTDs or IPF and healthy controls. Patients with a positive expression of anti–MDA‐5 antibodies developed significantly more skin ulcerations (12 of 15 versus 4 of 49; P < 0.001) and interstitial lung disease (ILD; 15 of 15 versus 31 of 49 [P = 0.003]) than those without anti–MDA‐5 antibodies. High‐resolution computed tomography scores of the MDA‐5–positive subset were increased compared with the MDA‐5–negative group (mean ± SD 117.7 ± 76.3 versus 54.4 ± 50.7; P = 0.004), and the scores correlated well with anti–MDA‐5 antibody levels (r 2 = 0.582, P = 0.029). The respiratory symptoms as well as skin ulcerations were dramatically improved in patients with anti–MDA‐5 antibody levels <500 units/ml after treatment, whereas patients with anti–MDA‐5 antibody levels >500 units/ml were resistant to the treatment and died of respiratory failure in a short period of time. Conclusion: Anti–MDA‐5 antibody levels closely correlate with the severity of skin ulcerations, ILD, and the prognosis of the disease. Dynamic observation of serum anti–MDA‐5 antibody levels would be helpful in predicting the course of ILD and facilitating better therapeutic targeting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888 · cited 1×
“MDA-5 senses intracellular viral infection and triggers innate antiviral responses, including the production of type I interferons, which further up-regulate MDA-5 to suppress viral replication and modulate the subsequent adaptive immunity (31,32).”
Background
Cited by
Autoantibodies in Polymyositis and Dermatomyositis
Ghirardello, A., Bassi, N., Palma, L., Borella, E., Domeneghetti, M., Punzi, L., & Doria, A. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0335-1 · Cited by 461
Satoh, M., Tanaka, S., Ceribelli, A., Calise, S. J., & Chan, E. K. L. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8510-y · Cited by 420
Chen, Z., Cao, M., Plana, M. N., Liang, J., Cai, H., Kuwana, M., & Sun, L. (2013) · Arthritis Care & Research · doi:10.1002/acr.21985 · Cited by 288
Self-citationDermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
Nombel, A., Fabien, N., & Coutant, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.773352 · Cited by 262
Metadata
- Authors
- Cao, H., Pan, M., Kang, Y., Xia, Q., Li, X., Zhao, X., Shi, R., Lou, J., Zhou, M., Kuwana, M., Ding, X., & Zheng, J.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2012-09-28
- Volume
- 64
- Issue
- 10
- Pages
- 1602-1610
- ISSN
- 0893-7524 (ISSN-L)
- 2151-464X
- 2151-4658
- OpenAlex
- W2042231174
- Cited by
- 187
- References
- 1
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti–melanoma differentiation–associated gene 5 antibody. https://app.cochat.ai/papers/10.1002/acr.21728
- The paper
- Cao, H., Pan, M., Kang, Y., Xia, Q., Li, X., Zhao, X., Shi, R., Lou, J., Zhou, M., Kuwana, M., Ding, X., & Zheng, J. (2012). Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti–melanoma differentiation–associated gene 5 antibody. Arthritis Care & Research. https://doi.org/10.1002/acr.21728
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.